logo-loader
RNS
Elementis plc

Third Quarter Trading Update

RNS Number : 7026A
Elementis PLC
28 October 2026
 

Elementis plc

Third Quarter Trading Update

 

FY26 adjusted operating profit expected to be in line with the latest market expectations1

Revenue up 7% for the nine months to September 20262

 

Elementis plc ("Elementis" or the "Group"), the pure-play specialty chemicals business, announces a scheduled trading update for the three months ended 30 September 2026.

 

Elementis now expects FY26 adjusted operating profit of $133-135 million, slightly above its previous guidance and in line with the latest market expectations1. The improved outlook reflects continued trading progress despite mixed market conditions. Our performance demonstrates good progress under the Elevate Elementis strategy launched in 2025 to accelerate sustainable growth, be the first choice for customers and build a simpler, leaner business.

 

Revenue up 7% for the nine months to September 20262

Revenue for the nine months to 30 September 2026 increased by 7% on an organic constant currency basis to $479 million, with particularly strong growth in Personal Care, continued momentum in Asia, and improved performance in the Americas.

 

In line with the Group’s typical seasonality, fourth quarter revenue is expected to be lower than in the third quarter which this year has benefitted from fulfilling earlier than anticipated customer orders. The Group remains on track to deliver further progress in the second half of the year.

 

 

Personal Care

Personal Care revenue growth accelerated in all regions, over a weaker prior year comparator, with further improvement in the Americas. Personal Care also benefitted from favourable order phasing in September. 

 

 

Coatings

The Energy business within Coatings continued to perform strongly, benefitting from further operational improvements at our St. Louis plant (US) and a good demand environment. Coatings performance in the Americas improved following a weak first half. Continued performance in Asia helped offset weaker results in EMEA in the quarter. Growth is expected to moderate in the fourth quarter reflecting a strong prior year comparator in Asia. 

 

 

Commenting on the results, Luc van Ravenstein, CEO, said:

“Our ‘Elevate Elementis’ strategy is progressing well, with revenue up 7%2 for the nine months to September 2026 despite mixed end market conditions.  This is being driven by Elementis’ high-quality capabilities in specialty chemicals and a simpler, leaner model that puts customers first.  We look forward to sharing more about our innovation that underpins this growth and differentiation at our Innovation Day next week.”

 

The person responsible for the release of this announcement on behalf of Elementis plc is Hannah Constantine, Group CLPO and Company Secretary.

Enquiries

Elementis plc

Luc van Ravenstein, Chief Executive Officer

Kath Kearney-Croft, Chief Financial Officer

 

FTI

Jamie Ricketts / Nick Hasell

 

Tel: +44 (0)20 8148 5966

 

 

 

Tel: +44 (0)20 3727 1000

 

Notes:

  1. Company compiled consensus, the mean adjusted operating profit for the year ended 31 December 2026:
    1. HY consensus : $132.5 million (range $129.4–136.5 million)
    2. Current consensus: $134.7 million (range $132.0-140.1 million).
  2. Organic constant currency rates are comparisons to the corresponding prior year period and determined as the reported rates excluding the impact of acquisitions and changes in the average translation exchange rates during the period.
  3. Elevate Elementis medium-term targets (i) Mid-single digit revenue growth through the cycle, (ii) Adjusted operating profit margin 23%+, (iii) Three-year operating cash conversion

>90%, (iv) Return on capital employed (excluding goodwill) >30%.


 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBOWRNRURUAA
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Director/PDMR Shareholding

3 days, 3 hours ago

Transaction in Own Shares

3 days, 5 hours ago

Transaction in Own Shares

1 week, 3 days ago

Innovation Day

2 weeks, 2 days ago

Director/PDMR Shareholding

2 weeks, 3 days ago

Transaction in Own Shares

2 weeks, 3 days ago

Director/PDMR Shareholding

2 weeks, 3 days ago

Transaction in Own Shares

3 weeks, 3 days ago

4 min read